This extensive receptor distribution may account for the antiatherosclerotic, endothelium-stabilizing, antiapoptotic, anti-inflammatory, antiobesity, and neurotrophic effects shown by GLP-1 in type 2 diabetes, obese, and dysmetabolic subjects (124). Here, GCG is linked to type 2 diabetes mellitus.